Showing results (1-10 of 106) with videos related to
Sort By:
Pageof 11
Seminars in Oncology|December 1, 1993
Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applicationsM A CaligiuriSeminars in Oncology|August 19, 2000
Acquired immunodeficiency syndrome-related lymphomas: future directionsP Porcu, M A CaligiuriBrazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1998
Interleukin-15 as a potential regulator of the innate immune responseW Carson, M A CaligiuriCurrent Opinion in Oncology|January 1, 1997
Developments in cytogenetics and oncogenes in acute leukemiaM P Strout, M A CaligiuriComparative Biochemistry and Physiology. A, Comparative Physiology|January 1, 1985
Prolonged diving and recovery in the freshwater turtle, Pseudemys scripta--IV. Effects of profound acidosis on O2 consumption in turtle vs rat (mammalian) brain and heart slicesM A Caligiuri, E D RobinBlood|February 1, 1997
Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune responseM E Ross, M A CaligiuriInternational Reviews of Immunology|March 7, 2002
Ontogeny and expansion of human natural killer cells: clinical implicationsT A Fehniger, M A CaligiuriCurrent Opinion in Oncology|November 5, 1999
Cytokines in the evolution and treatment of AIDS-lymphomaR A Baiocchi, M A CaligiuriProceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytesR A Baiocchi, M A CaligiuriPageof 11